Bayer secured a Supreme Court victory last week that will provide a liability shield against failure-to-warn lawsuits for harms caused by pesticides, including Roundup and its active ingredient, glyphosate. The company has been paying out large lawsuit settlements with 65,000 pending cases. Many of the cases allege an association between glyphosate and Non-Hodgkin’s Lymphoma. While there is a liability-shield effect from this court ruling, it doesn’t rule out other methods of bringing lawsuits against pesticide manufacturers for harm caused by products determined safe by the EPA.

Carl Tobias, a law professor at the University of Richmond who teaches about mass-tort cases, told Claims Journal that there are still negligence and marketing claims that can be brought against Bayer and other pesticide manufacturers.

“Juries can still hand down billion-dollar verdicts against Bayer on grounds other than failure-to-warn,” Tobias said. “This is not the silver bullet Bayer was looking for to end all Roundup litigation.”

Bates v Dow Agrosciences LLC, a 2005 Supreme Court case, actually set a precedent that other types of cases do not fall under federal preemption the way failure-to-warn claims do. This includes claims for defective design, defective manufacturing, negligent testing, and breach of express warranty.

Last week’s case only determined that in the case of failure-to-warn claims, federal preemption laws prevent states from bringing these types of claims against manufacturers. The EPA is responsible for testing the chemicals to determine whether they are safe, and they determine the warnings that need to appear on labels. For this reason, the Supreme Court justices ruled 7-2 in favor of Bayer, with Justices Neil Gorsuch and Ketanji Brown Jackson as the only dissenters.

“Durnell’s state tort claim would require Monsanto to add a cancer warning to Roundup’s label even though federal law requires Monsanto to use the EPA-approved label without a cancer warning,” wrote Justice Brett Kavanaugh in the majority opinion. “Because Durnell’s state tort claim would impose a pesticide labeling requirement ‘in addition to or different from’ the label required by EPA, FIFRA expressly preempts Durnell’s claim.”

Jackson and Gorsuch disagreed on the grounds that states were not creating new laws or labeling requirements, but rather allowing lawsuits based on state laws that parallel federal lawsuits. For this reason, they argued that federal preemption doesn’t apply.

“Durnell’s failure-to-warn claim is not ‘in addition to or different from’ FIFRA’s mandates; it is equivalent to FIFRA’s key labeling requirement—the misbranding prohibition,” Justice Jackson wrote. “And Durnell’s claim does not conflict with any other FIFRA ‘requirement’ for §136v(b) purposes because the EPA’s registration of a pesticide and approval of its label do not create a labeling requirement under FIFRA.”

“Ultimately, the effect of the majority’s interpretation is both remarkable and regrettable, for it unjustifiably closes the courthouse doors to state tort plaintiffs like Durnell,” Jackson added.

The EPA has long determined that glyphosate is “not likely to be carcinogenic to humans,” a conclusion that relied heavily on the results of a now-retracted paper ghostwritten by Monsanto executives. Following the latest Supreme Court ruling, failure-to-warn claims are generally barred unless the company violates the EPA-approved label.

Bayer executives had a private meeting with EPA officials in the Trump administration last year to give a small thanks for updating the glyphosate website. Specifically, the website included an EPA letter reaffirming the safety of glyphosate and an official letter stating that the agency would not approve a label that includes a cancer warning.

The private meeting included EPA officials who have ties to the agrochemical industry, and they discussed the Supreme Court case. The Trump administration also wrote a brief to the Supreme Court to support Bayer in the case.

EPA administrator Lee Zeldin was pressed in an April Congressional hearing by Representative Alexandria Ocasio-Cortez. In that exchange, Zeldin initially denied meeting with Bayer, but then explained he had only a brief meeting that didn’t involve discussions about the Supreme Court case. Zeldin was not one of the named individuals who were involved in the June 2025 private meeting.

The EPA’s ongoing review of glyphosate is expected to be completed in 2026, after a court vacated the human health portion of the agency’s 2020 review. The EPA’s cancer paper said a conclusion could not be determined regarding an association between glyphosate exposure and Non-Hodgkin’s Lymphoma. The court ruled that the EPA could not reasonably conclude that glyphosate is not likely to cause cancer while not being able to reach a conclusion on NHL. The human health portion was vacated in 2022 as a result of this internal inconsistency, and the review has subsequently been pushed back until 2026.

Bayer CEO Bill Anderson celebrated the Supreme Court decision. “This litigation has enormous costs for the company and has impacted public trust,” he said. “The decision brings overdue justice on an issue that should have been clarified much earlier. It’s time to put it behind us. Strengthened by this ruling, we continue to pursue our multi-pronged containment strategy, which includes the previously announced class settlement.”

Days after the ruling, Bayer filed a petition with the U.S. Department of Commerce and International Trade Commission seeking antidumping and countervailing duties on glyphosate imported from China. Bayer is the only US producer of glyphosate and stands to have a stronger market share with President Trump’s February executive order invoking the Defense Production Act to manufacture glyphosate domestically.

Steven Middendorp

Steven Middendorp is an investigative journalist, musician, and teacher. He has been a freelance writer and journalist for over 20 years. More recently, he has focused on issues dealing with corruption and negligence in the judicial system. He is a homesteading hobby farmer who encourages people to grow their own food, eat locally, and care for the land that provides sustenance to the community.

Other Headlines

Coronavirus

Florida Sues Pfizer, Alleging COVID Vaccine Safety and Transmission Claims Were Deceptive

“Pfizer’s marketing campaign that drove record-breaking profits rested on deception and falsehoods,” according to a lawsuit filed by Florida Attorney General James Uthmeier against Pfizer for the way the company promoted its mRNA COVID-19 vaccine. The lawsuit alleges that Pfizer CEO Albert Bourla and the company made false and deceptive claims about the vaccine’s safety,…Continue reading Florida Sues Pfizer, Alleging COVID Vaccine Safety and Transmission Claims Were Deceptive

More news about Coronavirus

Health & Nutrition

GLP-1s for 6-Year-Olds; Trial Shows BMI Reduction and Slower Height Growth In Young Children

A Novo Nordisk-funded trial published this week in the New England Journal of Medicine and presented at ObesityWeek is being promoted as evidence that weekly semaglutide (Wegovy) can reduce BMI in children ages 6 to under 12 with obesity. The results show a 13.5% drop in BMI at 68 weeks on the drug versus a…Continue reading GLP-1s for 6-Year-Olds; Trial Shows BMI Reduction and Slower Height Growth In Young Children

More news about Health & Nutrition

Vaccines

GSK Settled  False Advertising Case About “Big Bad Wolf” Pertussis Vaccine Ads. CNN and the CDC Are Still Selling the Same Claim

Informed Consent Action Network (ICAN) helped support a lawsuit that reached a settlement in a case against GlaxoSmithKline (GSK) alleging false advertising through its “Big Bad Cough” campaign, which encouraged grandparents to get the pertussis vaccine. The ad showed a grandparent transforming into a big bad wolf character, like in “Little Red Riding Hood,” because…Continue reading GSK Settled  False Advertising Case About “Big Bad Wolf” Pertussis Vaccine Ads. CNN and the CDC Are Still Selling the Same Claim

More news about Vaccines

Science & Tech

Lawsuit Alleges Google’s Gemini “Diagnosed” a 13-Year-Old and Helped Her Plan Suicide

Google’s Gemini AI convinced a 13-year-old girl that “she was afflicted by a battery of major psychological disorders, which ultimately led [her] to believe that suicide was the only way to escape her suffering,” according to a lawsuit filed earlier this month in California. The lawsuit against Google LLC and parent company Alphabet Inc. alleges…Continue reading Lawsuit Alleges Google’s Gemini “Diagnosed” a 13-Year-Old and Helped Her Plan Suicide

More news about Science & Tech

Environment

A Nonprofit Wants to Spray 25,000 Tons of Sulfur Dioxide; It Calls That “Research,” Not Deployment

A San Francisco nonprofit called Reflective has published a plan to spray sulfur dioxide into the stratosphere, first by the ton and later by the thousands of tons, and to treat the result as a research step toward “monitored cooling” of the planet. The company said it does not advocate “deployment,” but they are advocating…Continue reading A Nonprofit Wants to Spray 25,000 Tons of Sulfur Dioxide; It Calls That “Research,” Not Deployment

More news about Environment

Policy

Trump Withdraws Heidi Overton’s FDA Nomination Amid Mifepristone Debate and MAHA Tensions

The Trump administration withdrew the nomination of Dr. Heidi Overton to lead the FDA the night before the Senate Health, Education, Labor and Pensions Committee was scheduled to vote on advancing her. A senior administration official told Axios that Overton “lacks the support on the Hill to move forward with her confirmation.” The same official…Continue reading Trump Withdraws Heidi Overton’s FDA Nomination Amid Mifepristone Debate and MAHA Tensions

More news about Policy